Creative Biolabs offers a comprehensive drug abuse safety panel screening service tailored to meet the unique challenges of therapeutic antibody and protein development. Our panel is designed to rigorously assess the abuse potential of novel drug candidates.

Understanding Drug Abuse

The development of effective and safe therapeutic agents is essential. Drugs that interact with the central nervous system (CNS) can present risks of misuse, addiction, and other adverse effects. To address these concerns, implementing drug abuse screening is essential. Drug abuse screening protects patient health, adheres to strict regulatory standards, and ensures that therapeutic candidates remain both effective and safe. By identifying and managing the potential for abuse early on, the process of gaining regulatory approval becomes more efficient, ultimately ensuring the availability of safe and innovative cancer therapies.

Our Comprehensive Screening Service

At Creative Biolabs, we provide a state-of-the-art drug abuse safety panel screening service specifically designed for the unique challenges of immuno-oncology drug discovery. Our panel contains a wide range of CNS targets, including various receptors, transporters, and ion channels. Utilizing cutting-edge assays, our panel provides an exhaustive evaluation that is critical for the development of safe and effective therapeutic agents.

• Diverse Functional Assays: Our panel utilizes state-of-the-art assays to provide a comprehensive profiling of drug candidates' pharmacological activities. Our panel integrates both receptor-ligand binding assays and advanced functional assays. This thorough evaluation rigorously assesses both agonist and antagonist modes of action, ensuring any abuse-related potentials are identified early.
• Comprehensive CNS Targets: The panel includes a wide sweep of assays to support a detailed analysis of potential CNS-related effects, covering various targets and offering extensive insights into the abuse potential of drug candidates.
• Regulatory Alignment: Our screening processes comply with FDA guidelines, providing robust data to satisfy regulatory requirements. This compliance aids our clients in facilitating smoother regulatory submissions while ensuring public safety.

Fig.1 Targets of Drug abuse safety panel.

Advantages

• Comprehensive CNS Target Coverage
  Our panel includes a wide range of CNS-related receptors, transporters, and ion channels, enabling in-depth assessment of potential abuse risks associated with novel therapeutics.
• Multiplex Functional Assays
  By integrating binding and functional assays, we provide a complete pharmacological profile to identify agonist and antagonist activities, helping detect abuse liability early.
• Immuno-Oncology Focused
  Tailored for antibody and protein drug development, our panel is optimized for safety testing in the context of immuno-oncology research.
• Expert Team & Advanced Technology
  Our service is powered by an experienced scientific team and cutting-edge assay platforms, ensuring high accuracy, reproducibility, and reliability.

Why Choose Creative Biolabs?

Creative Biolabs has extensive experience in the field of drug safety testing and a proven track record of supporting immuno-oncology drug development. Our drug abuse safety panel screening service is conducted by experts who understand the complexities of drug development and the rigorous demands of safety testing. By partnering with Creative Biolabs, drug developers gain access to cutting-edge technologies and robust screening methodologies that ensure their therapies meet the highest standards of safety.

Contact us today to discover how our services support your drug discovery endeavors.

For Research Use Only | Not For Clinical Use